|
|
||||||||
TRANSLATIONAL AND CLINICAL RESEARCH |
aTexas Transplant Institute, San Antonio, Texas, USA;
bUniversity of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Key Words. Granulocyte colony-stimulating factor • Granulocyte-macrophage colony-stimulating factor • Graft versus host disease • Dentritic cells • Mobilization
Correspondence: Paul J. Shaughnessy, M.D., 8201 Ewing Halsell, Suite 280, San Antonio, Texas 78229, USA. Telephone: 210-575-8500; Fax: 210-575-8506; email: Paul.Shaughnessy{at}MHShealth.com
Received October 8, 2005;
accepted for publication March 13, 2006.
Dendritic cells (DCs) are effective antigen-presenting cells. We hypothesized that increasing the DC populations in donor lymphocyte infusions (DLIs) may augment the graft versus malignancy effect, particularly if granulocyte-macrophage colony-stimulating factor (GM-CSF) mobilization resulted in increased precursor dendritic cell (pDC) 1 cells. Mature DCs, pDC1 cells, pDC2 cells, and CD34+ cells from the same donor were compared after granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood stem cell collections and GM-CSF mobilized DLI collections. Mobilization with G-CSF resulted in up to a 10-fold larger number of CD34+ cells per kg and a 35-fold larger number of mature DCs, pDC1 cells, and pDC2 cells within the same donor compared with GM-CSF. The ratio of pDC1 to pDC2 in each donor remained constant with either cytokine. In this small sample of normal donors, it appears that G-CSF mobilizes more CD34+ cells, mature DCs, pDC1 cells, and pDC2 cells within the same donor than does GM-CSF, with no significant polarization by G-CSF or GM-CSF for either pDC1 or pDC2 cells.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
